July 20, 2022 Comments Off on New patent for Alkermes Inc drug LYBALVI Posted in: Patent Added Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Alkermes Inc drug LYBALVI appeared first on DrugPatentW…
July 20, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…